A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy
Title:
A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy
Author:
Henricks, Linda M. Lunenburg, Carin A.T.C. de Man, Femke M. Meulendijks, Didier Frederix, Geert W.J. Kienhuis, Emma Creemers, Geert-Jan Baars, Arnold Dezentjé, Vincent O. Imholz, Alexander L.T. Jeurissen, Frank J.F. Portielje, Johanna E.A. Jansen, Rob L.H. Hamberg, Paul ten Tije, Albert J. Droogendijk, Helga J. Koopman, Miriam Nieboer, Peter van de Poel, Marlène H.W. Mandigers, Caroline M.P.W. Rosing, Hilde Beijnen, Jos H. van Werkhoven, Erik van Kuilenburg, André B.P. van Schaik, Ron H.N. Mathijssen, Ron H.J. Swen, Jesse J. Gelderblom, Hans Cats, Annemieke Guchelaar, Henk-Jan Schellens, Jan H.M.